Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Related Articles ...

The group cast aside evidence-based science in favor of anti-vaccine propaganda and dangerous falsehoods that will hurt ...

The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease: hope. Pancreatic cancer is notorious for the swiftness with which it kills.

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Related Stories Texas will put warning labels on some foods, but its additives list has ...